{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T20:34:54Z","timestamp":1791059694619,"version":"4.1.0"},"reference-count":115,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2013,12,18]],"date-time":"2013-12-18T00:00:00Z","timestamp":1387324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Chemotherapy is one of the major modalities in treating cancers. However, its effectiveness is limited by the acquisition of multidrug resistance (MDR). Several mechanisms could explain the up-regulation of MDR genes\/proteins in cancer after chemotherapy. It is known that cancer stem cells (CSCs) play a role as master regulators. Therefore, understanding the mechanisms that regulate some traits of CSCs may help design efficient strategies to overcome chemoresistance. Different CSC phenotypes have been identified, including those found in some pediatric malignancies. As solid tumors in children significantly differ from those observed in adults, this review aims at providing an overview of the mechanistic relationship between MDR and CSCs in common solid tumors, and, in particular, focuses on clinical as well as experimental evidence of the relations between CSCs and MDR in neuroblastoma and hepatoblastoma. Finally, some novel approaches, such as concomitant targeting of multiple key transcription factors governing the stemness of CSCs, as well as nanoparticle-based approaches will also be briefly addressed.<\/jats:p>","DOI":"10.3390\/ijms141224706","type":"journal-article","created":{"date-parts":[[2013,12,18]],"date-time":"2013-12-18T14:55:38Z","timestamp":1387378538000},"page":"24706-24725","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":88,"title":["Multidrug Resistance and Cancer Stem Cells in Neuroblastoma and Hepatoblastoma"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7241-6329","authenticated-orcid":false,"given":"Anna","family":"Alisi","sequence":"first","affiliation":[{"name":"Liver Research Unit, \"Bambino Ges\u00f9\" Children's Hospital, IRCCS, Rome 00165, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7301-8151","authenticated-orcid":false,"given":"William","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Queen Elizabeth Hospital, 30 Gascoigne Road, Kowloon, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Locatelli","sequence":"additional","affiliation":[{"name":"Department of Oncohematology, \"Bambino Ges\u00f9\" Children's Hospital, IRCCS, Rome 00165, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doriana","family":"Fruci","sequence":"additional","affiliation":[{"name":"Department of Oncohematology, \"Bambino Ges\u00f9\" Children's Hospital, IRCCS, Rome 00165, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2013,12,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1146\/annurev.med.53.082901.103929","article-title":"Mechanisms of cancer drug resistance","volume":"53","author":"Gottesman","year":"2002","journal-title":"Annu. Rev. Med"},{"key":"ref_2","first-page":"127","article-title":"Overview of tumor cell chemoresistance mechanisms","volume":"111","author":"Gatti","year":"2005","journal-title":"Methods Mol. Med"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"x315","DOI":"10.1093\/annonc\/mdl280","article-title":"Chemoresistance in solid tumours","volume":"17","author":"Wilson","year":"2006","journal-title":"Ann. Oncol"},{"key":"ref_4","first-page":"1","article-title":"Cancer multidrug resistance (MDR): A major impediment to effective chemotherapy","volume":"9","author":"Ullah","year":"2008","journal-title":"Asian Pac. J. Cancer Prev"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nrc2789","article-title":"ABC transporters in cancer: More than just drug efflux pumps","volume":"10","author":"Fletcher","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nature09781","article-title":"Cells of origin in cancer","volume":"469","author":"Greaves","year":"2011","journal-title":"Nature"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ccr.2012.03.003","article-title":"Cancer stem cells: Impact, heterogeneity, and uncertainty","volume":"21","author":"Magee","year":"2012","journal-title":"Cancer Cell"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.coph.2010.05.002","article-title":"New models for cancer research: Human cancer stem cell xenografts","volume":"10","author":"Baiocchi","year":"2010","journal-title":"Curr. Opin. Pharmacol"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2001-1326-2-3","article-title":"Mechanisms of chemoresistance in cancer stem cells","volume":"2","author":"Abdullah","year":"2013","journal-title":"Clin. Transl. Med"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/clpt.2011.14","article-title":"Multidrug efflux pumps and cancer stem cells: Insights into multidrug resistance and therapeutic development","volume":"89","author":"Moitra","year":"2011","journal-title":"Clin. Pharmacol. Ther"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/S1470-2045(11)70257-1","article-title":"The developing cancer stem-cell model: Clinical challenges and opportunities","volume":"13","author":"Vermeulen","year":"2012","journal-title":"Lancet Oncol"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nm.2304","article-title":"The cancer stem cell: Premises, promises and challenges","volume":"17","author":"Clevers","year":"2011","journal-title":"Nat. Med"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature05372","article-title":"A human colon cancer cell capable of initiating tumour growth in immunodeficient mice","volume":"445","author":"Pollett","year":"2007","journal-title":"Nature"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hep.22704","article-title":"Liver stem cells and hepatocellular carcinoma","volume":"49","author":"Reddy","year":"2009","journal-title":"Hepatology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"16636","DOI":"10.3390\/ijms131216636","article-title":"The implications of cancer stem cells for cancer therapy","volume":"13","author":"Jiang","year":"2012","journal-title":"Int. J. Mol. Sci"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3390\/cancers3010298","article-title":"Cancer Stem Cells and Pediatric Solid Tumors","volume":"3","author":"Friedman","year":"2011","journal-title":"Cancers"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1101\/gr.184901","article-title":"The human ATP-binding cassette (ABC) transporter superfamily","volume":"11","author":"Dean","year":"2001","journal-title":"Genome Res"},{"key":"ref_19","unstructured":"Available online: http:\/\/nutrigene.4t.com\/humanabc.htm."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1182\/blood-2004-05-2056","article-title":"A novel missense mutation in ABCA1 results in altered protein trafficking and reduced phosphatidylserine translocation in a patient with Scott syndrome","volume":"106","author":"Albrecht","year":"2005","journal-title":"Blood"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/ng0198-11","article-title":"Retinitis pigmentosa caused by a homozygous mutation in the Stargardt disease gene ABCR","volume":"18","author":"Paloma","year":"1998","journal-title":"Nat. Genet"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S1089-3261(05)70139-2","article-title":"Progressive familial intrahepatic cholestasis. Genetic basis and treatment","volume":"4","author":"Jacquemin","year":"2000","journal-title":"Clin. Liver Dis"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1023\/A:1012823120935","article-title":"Complete characterization of the human ABC gene family","volume":"33","author":"Dean","year":"2001","journal-title":"J. Bioenerg. Biomembr"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1529-1049(03)00007-2","article-title":"P-glycoprotein and alloimmune T-cell activation","volume":"4","author":"Pendse","year":"2003","journal-title":"Clin. Appl. Immunol. Rev"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0005-2736(99)00168-6","article-title":"Structural, mechanistic and clinical aspects of MRP1","volume":"1461","author":"Hipfner","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/hep.510230519","article-title":"Absence of the canalicular isoform of the MRP gene-encoded conjugate export pump from the hepatocytes in Dubin-Johnson syndrome","volume":"23","author":"Kartenbeck","year":"1996","journal-title":"Hepatology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/bjc.1997.414","article-title":"The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancer","volume":"76","author":"Nooter","year":"1997","journal-title":"Br. J. Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/S0140-6736(05)63876-7","article-title":"Multidrug resistance protein in recurrent breast cancer","volume":"349","author":"Nooter","year":"1997","journal-title":"Lancet"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1023\/A:1025751631115","article-title":"Expression of MRP1, LRP and Pgp in breast carcinoma patients treated with preoperative chemotherapy","volume":"81","author":"Rudas","year":"2003","journal-title":"Breast Cancer Res. Treat"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00432-004-0653-9","article-title":"Multidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: Prognostic implications","volume":"131","author":"Berger","year":"2005","journal-title":"J. Cancer Res. Clin. Oncol"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/bjc.1995.372","article-title":"Expression of the multidrug resistance-associated protein (MRP) gene in non-small-cell lung cancer","volume":"72","author":"Ota","year":"1995","journal-title":"Br. J. Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s004080000091","article-title":"Relationship between chemotherapy response of small cell lung cancer and P-glycoprotein or multidrug resistance-related protein expression","volume":"180","author":"Hsia","year":"2002","journal-title":"Lung"},{"key":"ref_33","first-page":"1059","article-title":"Multidrug resistance-associated protein and mutant p53 protein expression in non-small cell lung cancer","volume":"11","author":"Oshika","year":"1998","journal-title":"Mod. Pathol"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0969-8051(03)00058-1","article-title":"To predict response chemotherapy using technetium-99m tetrofosmin chest images in patients with untreated small cell lung cancer and compare with p-glycoprotein, multidrug resistance related protein-1, and lung resistance-related protein expression","volume":"30","author":"Kuo","year":"2003","journal-title":"Nucl. Med. Biol"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.febslet.2005.12.036","article-title":"Substrate recognition and transport by multidrug resistance protein 1 (ABCC1)","volume":"580","author":"Deeley","year":"2006","journal-title":"FEBS Lett"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1056\/NEJM199601253340405","article-title":"Expression of the gene for multidrug-resistance\u2013associated protein and outcome in patients with neuroblastoma","volume":"334","author":"Norris","year":"1996","journal-title":"N. Engl. J. Med"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1002\/cncr.10858","article-title":"The role of the MDR1 gene in the development of multidrug resistance in human hepatoblastoma: Clinical course and in vivo model","volume":"95","author":"Warmann","year":"2002","journal-title":"Cancer"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jpedsurg.2008.10.088","article-title":"Increased expression of multidrug resistance-associated genes after chemotherapy in pediatric solid malignancies","volume":"44","author":"Oue","year":"2009","journal-title":"J. Pediatr. Surg"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMra0804577","article-title":"Recent advances in neuroblastoma","volume":"362","author":"Maris","year":"2010","journal-title":"N. Engl. J. Med"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrc3526","article-title":"Neuroblastoma: Developmental biology, cancer genomics and immunotherapy","volume":"13","author":"Cheung","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1126\/science.6719137","article-title":"Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage","volume":"224","author":"Brodeur","year":"1984","journal-title":"Science"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1056\/NEJM198510313131802","article-title":"Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas","volume":"313","author":"Seeger","year":"1985","journal-title":"N. Engl. J. Med"},{"key":"ref_43","first-page":"5036","article-title":"Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma","volume":"54","author":"Bordow","year":"1994","journal-title":"Cancer Res"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/S0959-8049(97)00284-0","article-title":"Evidence that the MYCN oncogene regulates MRP gene expression in neuroblastoma","volume":"33","author":"Norris","year":"1997","journal-title":"Eur. J. Cancer"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1038\/sj.onc.1202859","article-title":"Altered expression of the MYCN oncogene modulates MRP gene expression and response to cytotoxic drugs in neuroblastoma cells","volume":"18","author":"Haber","year":"1999","journal-title":"Oncogene"},{"key":"ref_46","first-page":"1143","article-title":"Expression analysis of multidrug resistance associated genes in neuroblastomas","volume":"6","author":"Bader","year":"1999","journal-title":"Oncol. Rep"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1093\/jnci\/djg045","article-title":"Effects of MYCN antisense oligonucleotide administration on tumorigenesis in a murine model of neuroblastoma","volume":"95","author":"Burkhart","year":"2003","journal-title":"J. Natl. Cancer Inst"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.canlet.2005.01.060","article-title":"The role of the multidrug resistance-associated protein 1 gene in neuroblastoma biology and clinical outcome","volume":"228","author":"Pajic","year":"2005","journal-title":"Cancer Lett"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/j.1349-7006.1998.tb00524.x","article-title":"Expression of MRP and cMOAT in childhood neuroblastomas and malignant liver tumors and its relevance to clinical behavior","volume":"89","author":"Matsunaga","year":"1998","journal-title":"Jpn. J. Cancer Res"},{"key":"ref_50","first-page":"1358","article-title":"Expression of multidrug resistance-related markers in primary neuroblastoma","volume":"117","author":"Lu","year":"2004","journal-title":"Chin. Med. J. (Engl.)"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/S0959-8049(97)00229-3","article-title":"The prognostic value of MDR1 gene expression in primary untreated neuroblastoma","volume":"33","author":"Haber","year":"1997","journal-title":"Eur. J. Cancer"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/jnci\/81.18.1401","article-title":"Correlation of MDR1 gene expression with chemotherapy in neuroblastoma","volume":"81","author":"Bourhis","year":"1989","journal-title":"J. Natl. Cancer Inst"},{"key":"ref_53","first-page":"3043","article-title":"Inverse correlation between expression of multidrug resistance gene and N-myc oncogene in human neuroblastomas","volume":"50","author":"Nakagawara","year":"1990","journal-title":"Cancer Res"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/bjc.1991.282","article-title":"Expression of P-glycoprotein restricted to normal cells in neuroblastoma biopsies","volume":"64","author":"Favrot","year":"1991","journal-title":"Br. J. Cancer"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJM199112053252304","article-title":"P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma","volume":"325","author":"Chan","year":"1991","journal-title":"N. Engl. J. Med"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/sj.onc.1207151","article-title":"MYCN-mediated regulation of the MRP1 promoter in human neuroblastoma","volume":"23","author":"Manohar","year":"2004","journal-title":"Oncogene"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1093\/jnci\/djr256","article-title":"ABCC multidrug transporters in childhood neuroblastoma: Clinical and biological effects independent of cytotoxic drug efflux","volume":"103","author":"Henderson","year":"2011","journal-title":"J. Natl. Cancer Inst"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1158\/1535-7163.MCT-04-0161","article-title":"Expression of multidrug transporter MRP4\/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro","volume":"4","author":"Norris","year":"2005","journal-title":"Mol. Cancer Ther"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"19532","DOI":"10.1074\/jbc.M109.078584","article-title":"Direct and coordinate regulation of ATP-binding cassette transporter genes by Myc factors generates specific transcription signatures that significantly affect the chemoresistance phenotype of cancer cells","volume":"285","author":"Porro","year":"2010","journal-title":"J. Biol. Chem"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/pbc.24215","article-title":"The epidemiology of hepatoblastoma","volume":"59","author":"Spector","year":"2012","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Terrada, D., Alaggio, R., de D\u00e1vila, M.T., Czauderna, P., Hiyama, E., Katzenstein, H., Leuschner, I., Malogolowkin, M., Meyers, R., and Ranganathan, S. (2013). Towards an international pediatric liver tumor consensus classification: Proceedings of the Los Angeles COG liver tumors symposium. Mod. Pathol.","DOI":"10.1038\/modpathol.2013.80"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.ejca.2005.02.004","article-title":"Guidelines for surgical treatment of hepatoblastoma in the modern era: Recommendations from the childhood liver tumour strategy group of the international society of paediatric oncology (SIOPEL)","volume":"41","author":"Czauderna","year":"2005","journal-title":"Eur. J. Cancer"},{"key":"ref_63","unstructured":"Available online: http:\/\/www.cancer.gov\/clinicaltrials\/search\/view?version=healthprofessional&cdrid=654889."},{"key":"ref_64","unstructured":"Wiederkehr, J.C., Coelho, I.M., Avilla, S.G., Wiederkehr, B.A., and Wiederkehr, H.A. (2013). Hepatic Surgery, InTech."},{"key":"ref_65","first-page":"559","article-title":"Overexpression of multidrug resistance genes MDR1 and cMOAT in human hepatocellular carcinoma and hepatoblastoma cell lines","volume":"15","author":"Minemura","year":"1999","journal-title":"Int. J. Oncol"},{"key":"ref_66","first-page":"3127","article-title":"Altered expression of resistance associated genes in hepatoblastoma xenografts incorporated in mice following treatment with doxorubicin or cisplatin","volume":"18","author":"Bader","year":"1998","journal-title":"Anticancer Res"},{"key":"ref_67","first-page":"4607","article-title":"P-glycoprotein modulation improves in vitro chemosensitivity in malignant pediatric liver tumors","volume":"23","author":"Warmann","year":"2003","journal-title":"Anticancer Res"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/08880010590964192","article-title":"Effects of P-glycoprotein modulation on the chemotherapy of xenotransplanted human hepatoblastoma","volume":"22","author":"Warmann","year":"2005","journal-title":"Pediatr. Hematol. Oncol"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrc1590","article-title":"Tumour stem cells and drug resistance","volume":"5","author":"Dean","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"ref_70","first-page":"447","article-title":"Development of a drug resistance model for hepatoblastoma","volume":"38","author":"Eicher","year":"2011","journal-title":"Int. J. Oncol"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"9339","DOI":"10.1158\/0008-5472.CAN-06-3126","article-title":"Cancer stem cells\u2014Perspectives on current status and future directions: AACR Workshop on cancer stem cells","volume":"66","author":"Clarke","year":"2006","journal-title":"Cancer Res"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1007\/s00018-011-0772-9","article-title":"Lessons from common markers of tumor-initiating cells in solid cancers","volume":"68","author":"Gires","year":"2011","journal-title":"Cell. Mol. Life Sci"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrc2499","article-title":"Cancer stem cells in solid tumours: Accumulating evidence and unresolved questions","volume":"8","author":"Visvader","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1096\/fj.12-218222","article-title":"Cancer stem cells in solid tumors: An overview and new approaches for their isolation and characterization","volume":"27","author":"Tirino","year":"2013","journal-title":"FASEB J"},{"key":"ref_75","first-page":"168","article-title":"Cancer stem cells in pediatric sarcomas","volume":"3","year":"2013","journal-title":"Front. Oncol"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"e3469","DOI":"10.1371\/journal.pone.0003469","article-title":"Detection and characterization of CD133+ cancer stem cells in human solid tumours","volume":"3","author":"Tirino","year":"2008","journal-title":"PLoS One"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1096\/fj.10-179036","article-title":"Human primary bone sarcomas contain CD133+ cancer stem cells displaying high tumorigenicity in vivo","volume":"25","author":"Tirino","year":"2011","journal-title":"FASEB J"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"e19506","DOI":"10.1371\/journal.pone.0019506","article-title":"CD133 positive embryonal rhabdomyosarcoma stem-like cell population is enriched in rhabdospheres","volume":"6","author":"Walter","year":"2011","journal-title":"PLoS One"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1038\/nm1297-1337","article-title":"Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species","volume":"3","author":"Goodell","year":"1997","journal-title":"Nat. Med"},{"key":"ref_80","first-page":"37","article-title":"Flow cytometry of the side population: Tips and tricks","volume":"28","author":"Celis","year":"2006","journal-title":"Cell. Oncol"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s13577-010-0002-z","article-title":"Clinical significance of side population in ovarian cancer cells","volume":"24","author":"Hosonuma","year":"2011","journal-title":"Hum. Cell"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1593\/tlo.09301","article-title":"Comparison of the side populations in pretreatment and postrelapse neuroblastoma cell lines","volume":"3","author":"Newton","year":"2010","journal-title":"Transl. Oncol"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.brainres.2003.08.061","article-title":"Neurosphere and neurosphere-forming cells: Morphological and ultrastructural characterization","volume":"993","author":"Bez","year":"2003","journal-title":"Brain Res"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1593\/neo.11800","article-title":"Functional sphere profiling reveals the complexity of neuroblastoma tumor-initiating cell model","volume":"13","author":"Coulon","year":"2011","journal-title":"Neoplasia"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1593\/neo.05394","article-title":"Stem-like cells in bone sarcomas: Implications for tumorigenesis","volume":"7","author":"Gibbs","year":"2005","journal-title":"Neoplasia"},{"key":"ref_86","first-page":"5821","article-title":"Identification of a cancer stem cell in human brain tumors","volume":"63","author":"Singh","year":"2003","journal-title":"Cancer Res"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1593\/neo.04310","article-title":"Characteristics of stem cells from human neuroblastoma cell lines and in tumors","volume":"6","author":"Walton","year":"2004","journal-title":"Neoplasia"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s12519-008-0012-z","article-title":"Expression and clinical significance of stem cell marker CD133 in human neuroblastoma","volume":"4","author":"Tong","year":"2008","journal-title":"World J. Pediatr"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Takenobu, H., Shimozato, O., Nakamura, T., Ochiai, H., Yamaguchi, Y., Ohira, M., Nakagawara, A., and Kamijo, T. CD133 suppresses neuroblastoma cell differentiation via signal pathway modification. Oncogene, 30, 97\u2013105.","DOI":"10.1038\/onc.2010.383"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s10147-012-0415-7","article-title":"Molecular and genetic bases of neuroblastoma","volume":"17","author":"Kamijo","year":"2012","journal-title":"Int. J. Clin. Oncol"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"11234","DOI":"10.1158\/0008-5472.CAN-07-0718","article-title":"Neuroblastoma cells isolated from bone marrow metastases contain a naturally enriched tumor-initiating cell","volume":"67","author":"Hansford","year":"2007","journal-title":"Cancer Res"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/gcc.21964","article-title":"Genotype analysis of tumor initiating cells expressing CD133 in neuroblastoma","volume":"51","author":"Cournoyer","year":"2012","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1158\/1078-0432.CCR-10-2075","article-title":"Neural tumor-initiating cells have distinct telomere maintenance and can be safely targeted for telomerase inhibition","volume":"17","author":"Zhang","year":"2011","journal-title":"Clin. Cancer Res"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/j.1750-3639.2010.00379.x","article-title":"The utility and limitations of neurosphere assay, CD133 immunophenotyping and side population assay in glioma stem cell research","volume":"20","author":"Wan","year":"2010","journal-title":"Brain Pathol"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"e2637","DOI":"10.1371\/journal.pone.0002637","article-title":"Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells","volume":"3","author":"Chen","year":"2008","journal-title":"PLoS One"},{"key":"ref_96","first-page":"203","article-title":"A distinct \u201cside population\u201d of cells in human tumor cells: Implications for tumor biology and therapy","volume":"4","author":"Foster","year":"2005","journal-title":"Cell Cycle"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/pbc.22351","article-title":"Resistance of stem-like cells from neuroblastoma cell lines to commonly used chemotherapeutic agents","volume":"54","author":"Vangipuram","year":"2010","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/(SICI)1096-9896(200005)191:1<102::AID-PATH542>3.0.CO;2-X","article-title":"Ep-CAM in malignant liver tumours","volume":"191","author":"Ruck","year":"2000","journal-title":"J. Pathol"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1478-3231.2009.02126.x","article-title":"Hepatic progenitor cells in liver cancers from Asian children","volume":"30","author":"Ward","year":"2010","journal-title":"Liver Int"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.prp.2013.06.015","article-title":"Clinicopathologic implication of hepatic progenitor cell marker expression in hepatoblastoma","volume":"209","author":"Yun","year":"2013","journal-title":"Pathol. Res. Pract"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"e22620","DOI":"10.4161\/onci.22620","article-title":"Targeting EpCAM (CD326) for immunotherapy in hepatoblastoma","volume":"2","author":"Hoh","year":"2013","journal-title":"Oncoimmunology"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/jemt.22237","article-title":"Detection of CD133 (prominin-1) in a human hepatoblastoma cell line (HuH-6 clone 5)","volume":"76","author":"Akita","year":"2013","journal-title":"Microsc. Res. Tech"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"9550","DOI":"10.1200\/jco.2010.28.15_suppl.9550","article-title":"Sorafenib, gamma-secretase inhibitor, and bortezomib as potential therapeutic agents for hepatoblastoma","volume":"28","author":"Chen","year":"2010","journal-title":"J. Clin. Oncol"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ccr.2008.11.002","article-title":"Hepatic stem-like phenotype and interplay of Wnt\/beta-catenin and Myc signaling in aggressive childhood liver cancer","volume":"14","author":"Cairo","year":"2008","journal-title":"Cancer Cell"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.yexmp.2010.05.005","article-title":"Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma","volume":"89","author":"Lingala","year":"2010","journal-title":"Exp. Mol. Pathol"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1046\/j.1365-2559.1997.2750870.x","article-title":"Hepatic stem-like cells in hepatoblastoma: Expression of cytokeratin 7, albumin and oval cell associated antigens detected by OV-1 and OV-6","volume":"31","author":"Ruck","year":"1997","journal-title":"Histopathology"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/01.MP.0000086486.52370.81","article-title":"Small cells in hepatoblastoma lack \u201coval\u201d cell phenotype","volume":"16","author":"Badve","year":"2003","journal-title":"Mod. Pathol"},{"key":"ref_108","first-page":"1081","article-title":"Cancer stem cell as a potential therapeutic target in hepatocellular carcinoma","volume":"12","author":"Pang","year":"2012","journal-title":"Curr. Cancer Drug Targets"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1369\/jhc.4A6297.2004","article-title":"Stem-like cells in human hepatoblastoma","volume":"52","author":"Fiegel","year":"2004","journal-title":"J. Histochem. Cytochem"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.bbrc.2013.06.050","article-title":"Germline traits of human hepatoblastoma cells associated with growth and metastasis","volume":"437","author":"Liu","year":"2013","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00383-010-2719-x","article-title":"Isolation and identification of cancer stem cells from a side population of a human hepatoblastoma cell line, HuH-6 clone-5","volume":"27","author":"Hayashi","year":"2011","journal-title":"Pediatr. Surg. Int"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/hep.25776","article-title":"Oncogene-specific formation of chemoresistant murine hepatic cancer stem cells","volume":"56","author":"Chow","year":"2012","journal-title":"Hepatology"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: An evolving paradigm","volume":"13","author":"Holohan","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"ref_114","unstructured":"Available online: http:\/\/www.sciencedaily.com\/releases\/2012\/09\/120910122114.htm."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1158\/1078-0432.CCR-09-2933","article-title":"The difficulty of targeting cancer stem cell niches","volume":"16","author":"LaBarge","year":"2010","journal-title":"Clin. Cancer Res"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/14\/12\/24706\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:51:28Z","timestamp":1760219488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/14\/12\/24706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,18]]},"references-count":115,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2013,12]]}},"alternative-id":["ijms141224706"],"URL":"https:\/\/doi.org\/10.3390\/ijms141224706","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,18]]}}}